AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Leucine + Metformin In Phase II Human Trials | Prof Michael Zemel Ep 3
Modern Healthspan
The Future of Weight Loss Drugs
We believe with further clinical development have a drug that can be highly accessible in a form that is easily taken orally. And really hit not only on weight, but on weight associated COVID or obesity associated comorbidities and improve overall cardiometabolic health. So we're planning our next trials now. And we are quite optimistic. Our weight loss data has already repeated itself in two-phase, two trials. Now the question is how to best optimize? Excellent. How to best optimize and also longer-term trials. We have up to six months. We need to take it out to a year and move into phase three for trials of that length and longer. That would be excellent
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode